skills.rest
vignesh2027
vignesh2027COMMUNITY
Explore all skills by this author →
GitHub

biotech-analyst

Analyze biotech pipelines, regulatory strategies, and valuations using rNPV and PoS calculations.

6|Updated May 20, 2026
Search Tags:#investment#biotech#regulatory-strategy#biotech-analysis#clinical-development#rnpv#ip-moat
One-click install
npx skills add https://github.com/vignesh2027/Claude-Agentic-Skills2.0-version --skill biotech-analyst
Or copy as Structured Prompt for Agent▼
Please help me install this Agent Skill.
Skill: biotech-analyst
Source: https://github.com/vignesh2027/Claude-Agentic-Skills2.0-version/tree/main/biotech-analyst
Command: npx skills add https://github.com/vignesh2027/Claude-Agentic-Skills2.0-version --skill biotech-analyst

SYSTEM DOCUMENTATION & REQUIREMENTS

What problem does it solve?

Activates BiotechAnalyst to support biotech and pharmaceutical investment and competitive analysis by delivering pipeline insights, regulatory strategy guidance, and robust valuation frameworks.

Core Features & Use Cases

  • Risk-adjusted NPV (rNPV) framework for drug programs.
  • Regulatory pathway assessment with FDA/EMA considerations.
  • Competitive landscape mapping by indication and MOA.
  • IP moat analysis and patent cliff risk assessment for drug programs.

Quick Start

Analyze a biotech program's pipeline, regulatory pathway, and valuation using rNPV and PoS calculations.

Frequently Asked Questions about biotech-analyst

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I calculate risk-adjusted NPV for a biotech pipeline?▼

Risk-adjusted NPV for a biotech pipeline is calculated by applying probability of success modeling to drug programs, discounting future cash flows, and mapping the competitive landscape to produce actionable investment insights.

What is regulatory strategy assessment for drug development?▼

Regulatory strategy assessment evaluates FDA and EMA pathway considerations for drug programs to guide clinical development planning, ensuring compliance and optimizing the approval trajectory for biotech investments.

How do I analyze an IP moat and patent cliff risk for pharmaceutical investments?▼

IP moat analysis assesses intellectual property barriers and patent cliff risks for drug programs to determine competitive durability, while rNPV calculations quantify the valuation impact of exclusivity loss.

Can I map the competitive landscape by indication and mechanism of action?▼

Yes, competitive landscape mapping by indication and mechanism of action is supported to guide venture capital and corporate development decisions, identifying market positioning and pipeline differentiation.

Does biotech valuation work for licensed pharma strategies and venture capital?▼

Biotech valuation applies to both venture capital and licensed pharma strategies, utilizing pipeline assessment, PoS estimation, and rNPV frameworks to evaluate drug programs and guide investment decisions.

Related Skills

Explore More Data & Analytics Skills→
patsnappatsnap
33

target-intelligence

Generate target intelligence reports from PatSnap life-science data.

Official
Advanced
lossless-grouplossless-group
4

Competitive Analysis Taxonomy

Classify competitors by funding stage ring and structural relationship type.

Official
Intermediate
luisschmitzheadlineluisschmitzheadline
23

market-research

Generate founder-focused market briefs with TAM/SAM/SOM and competitive landscape.

Community
Intermediate
robinbarvaagrobinbarvaag

drugbank-database

Query DrugBank database for drug properties, interactions, targets, and pathways.

Community
Advanced